These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 3620)

  • 21. Acid beta-glucosidase and the diagnosis of Gaucher's disease in liver and spleen.
    Butterworth J; Broadhead DM
    Clin Chim Acta; 1978 Aug; 87(3):433-40. PubMed ID: 28186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The common identity of five glycosidases in human liver.
    Chester MA; Hultberg B; Ockerman PA
    Biochim Biophys Acta; 1976 Apr; 429(2):517-26. PubMed ID: 1260036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterozygote detection of type I Gaucher disease using blood platelets.
    Nakagawa S; Kumin S; Sachs G; Nitowsky HM
    Clin Chim Acta; 1982 Jan; 118(1):99-107. PubMed ID: 6797762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of lysosomal enzymes in chick embryo fibroblasts infected with microorganisms of family Halprowiaceae (Chlamydiaceae)].
    Lukomskaia IS; Beskina SR; Kartavchenko TP
    Biokhimiia; 1977 Jan; 42(1):144-50. PubMed ID: 557998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Laboratory diagnosis of Gaucher's disease. Value of leukocyte beta-glucosidase determination].
    Turpin JC; Bauman N; Castaigne P
    Nouv Presse Med; 1972 Jun; 1(23):1579-81. PubMed ID: 5035886
    [No Abstract]   [Full Text] [Related]  

  • 26. Leukocyte glucocerebrosidase deficiency diagnostic in adult Gaucher's disease with negative bone marrow biopsy. Some properties of the enzyme in leukocytes and spleen.
    Klibansky C; Hoffmann J; Pinkhas J; Algom D; Dintzman M; Ben-Bassat M; De Vries A
    Eur J Clin Invest; 1974 Apr; 4(2):101-7. PubMed ID: 4832717
    [No Abstract]   [Full Text] [Related]  

  • 27. Glycosidases of the retinal pigment epithelium.
    Lentrichia BB; Bruner WE; Kean EL
    Invest Ophthalmol Vis Sci; 1978 Sep; 17(9):884-95. PubMed ID: 700967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme replacement therapy in Gaucher's and Fabry's disease.
    Pentchev PG
    Ann Clin Lab Sci; 1977; 7(3):251-3. PubMed ID: 404951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum lysosomal acid hydrolase activities in Graves' disease.
    Guillou H; David V; Lorcy Y; Le Treut A; Allannic H; Le Gall JY
    Clin Chim Acta; 1982 Apr; 120(2):219-24. PubMed ID: 6802524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A modified method for the identification of heterozygotes for Gaucher's disease using differential thermal inactivation.
    Goodman C; O'Brien JS
    Clin Genet; 1980 Sep; 18(3):226-31. PubMed ID: 6777098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoenzyme profiles of lysosomal hydrolases in leukaemic cells.
    Dewji N; Rapson N; Greaves M; Ellis R
    Leuk Res; 1981; 5(1):19-27. PubMed ID: 6262581
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of N-hexyl-O-glucosyl sphingosine on normal cultured human fibroblasts: a chemical model for Gaucher's disease.
    Warren KR; Schafer IA; Sullivan JC; Petrelli M; Radin NS
    J Lipid Res; 1976 Mar; 17(2):132-8. PubMed ID: 178814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative studies of the acid hydrolases of human leucocytes and human and guinea pig alveolar macrophages. I. Study of the activities of glycosidases, arylsulfatase and acid phosphatase (author's transl)].
    Scharfman A; Houdret N; Roussel P; Biserte G; Aerts C; Tonnel AB; Voisin C
    Clin Chim Acta; 1975 Sep; 63(3):369-76. PubMed ID: 1175306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysosomal enzyme activities during ageing of adult human liver cell lines.
    Le Gall JY; Khoi TD; Glaise D; Le treut A; Brissot P; Guillouzo A
    Mech Ageing Dev; 1979 Nov; 11(4):287-93. PubMed ID: 522513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
    Garrett KO; Prence EM; Glew RH
    Arch Biochem Biophys; 1985 Apr; 238(1):344-52. PubMed ID: 3920967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of lysosomal hydrolases that are elevated in Gaucher's disease.
    Moffitt KD; Chambers JP; Diven WF; Glew RH; Wenger DA; Farrell DF
    Arch Biochem Biophys; 1978 Sep; 190(1):247-60. PubMed ID: 101149
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro correction of deficient human fibroblasts by beta-glucuronidase from different human sources.
    Brot FE; Glaser JH; Roozen KJ; Sly WS; Stahl PD
    Biochem Biophys Res Commun; 1974 Mar; 57(1):1-8. PubMed ID: 4857181
    [No Abstract]   [Full Text] [Related]  

  • 38. Detection of Fabry's disease heterozygotes by hair root analysis.
    Beaudet AL; Caskey CT
    Clin Genet; 1978 Mar; 13(3):251-8. PubMed ID: 205381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional study of acid hydrolases and lysosomal membrane properties in the normal human brain at various ages.
    Brun A; Hultberg B
    Mech Ageing Dev; 1975; 4(3-4):201-13. PubMed ID: 561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of serum concentration, type of culture medium and pH on the lysosomal enzyme activity of cultured human amniotic fluid cells.
    Butterworth J; Sutherland GR; Broadhead DM; Bain AD
    Clin Chim Acta; 1974 Jun; 53(2):239-46. PubMed ID: 4858313
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.